文献速递消化道肿瘤放疗放疗物理与技术

胰腺癌切缘近/阳性术后辅助SBRT失败模式

Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins.
PubMed 文献 · Adv Radiat Oncol · 2020-08-26

中位随访17.0个月,2年局部失败、区域失败、局部区域失败与远处失败累积发生率分别为34.9%、30.8%、49.2%和60.4%,多数局部失败位于PTV之外但落在RTOG共识靶区内。

要点

  • 切缘近占51.3%、阳性占48.7%,多数患者接受36 Gy分3次照射。
  • 2年局部区域失败累积发生率为49.2%,远处失败为60.4%。
  • 可复核局部失败中60.7%完全在PTV外,但92.9%在RTOG共识靶区内。

核心结论

  • 胰腺癌切缘近/阳性术后辅助SBRT后,多数局部失败位于PTV之外,但落在现行常规放疗共识靶区内。

研究设计与样本

  • 失败模式定义为肿瘤床内局部失败、淋巴结或吻合口区域失败及远处失败,局部失败按与PTV关系分为野内、边缘和野外。
  • 采用累积发生函数并在考虑死亡竞争风险下计算局部区域失败累积发生率,并将局部失败位置与RTOG 0848勾画图谱比对。

主要发现

  • 切缘近占51.3%、阳性占48.7%;81.6%接受36 Gy分3次,中位PTV体积17.8 cc(四分位距12.1-25.6)。
  • 中位随访17.0个月(四分位距7.3-28.4),首次孤立局部失败、孤立区域失败及远处失败±局部或区域失败的粗率分别为9.2%、6.6%和56.6%。
  • 2年局部失败、区域失败、局部区域失败和远处失败累积发生率分别为34.9%、30.8%、49.2%和60.4%。
  • 28例可复核局部失败中21.4%为野内,60.7%完全在PTV外,17.9%部分在PTV外;92.9%的局部失败可被RTOG共识靶区覆盖。

关键数值与推荐

  • 局部失败分类:野内为完全位于PTV内,边缘为部分位于PTV内,野外为完全位于PTV外。
  • 局部失败位置与RTOG 0848勾画图谱比对,判断标准术后放疗靶区是否覆盖局部失败。
  • 2年局部区域失败累积发生率为49.2%,远处失败为60.4%。

临床怎么用

  • 提示辅助SBRT的PTV设计可能偏小,制定靶区时可参考RTOG共识术后靶区范围以覆盖潜在局部失败区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: There is no consensus on treatment volumes for adjuvant stereotactic body radiation therapy (SBRT) for pancreatic cancer. Herein, we report patterns of failure after pancreatic SBRT for close/positive margins, which may inform target volume design. METHODS AND MATERIALS: An institutional review board-approved retrospective review of patients with pancreatic adenocarcinoma treated with adjuvant SBRT for close/positive margins from 2009 to 2018 was conducted. Patterns of failure were defined as local (LF) within the tumor bed, regional (RF) within lymph nodes or anastomoses, or distant (DF). The cumulative incidence of locoregional failure was calculated using the cumulative incidence function accounting for the competing risk of death. LFs were mapped to the planning target volume (PTV) and classified as in-field (completely within the PTV), marginal (partially within the PTV), or out-of-field (completely outside the PTV). The location of LFs was compared with the Radiation Therapy Oncology Group 0848 contouring atlas to determine whether standard postoperative radiation therapy volumes would have included the LF. RESULTS: Seventy-six patients were treated with adjuvant SBRT for close (51.3%) or positive (48.7%) margins. Most (81.6%) received 36 Gy in 3 fractions, with a median PTV volume of 17.8 cc (interquartile range, 12.1-25.6). With a median follow-up of 17.0 months (interquartile range, 7.3-28.4), crude rates of first isolated LF, isolated RF, and DF +/- LF or RF were 9.2%, 6.6%, and 56.6%, respectively. Two-year cumulative incidences of LF, RF, locoregional failure, and DF were 34.9%, 30.8%, 49.2%, and 60.4%, respectively. Of 28 reviewable LFs, 21.4% were in-field while the remainder were completely outside (60.7%) or partially outside (17.9%) the PTV. Most LFs (92.9%) would have been encompassed by the Radiation Therapy Oncology Group consensus target volumes. CONCLUSIONS: After adjuvant pancreatic SBRT for close/positive margins, the majority of LFs were outside the PTV but within contemporary target volumes for conventional radiation therapy.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Patel AK, Rodríguez-López JL, Bahary N, et al. Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins. Adv Radiat Oncol. 2020. PMID: 33305081. doi:10.1016/j.adro.2020.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。